Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years

被引:58
作者
Taraborelli, M. [1 ]
Cavazzana, I. [1 ]
Martinazzi, N. [2 ]
Lazzaroni, M. Grazia [2 ]
Fredi, M. [1 ]
Andreoli, L. [2 ]
Franceschini, F. [1 ]
Tincani, A. [1 ,2 ]
机构
[1] Spedali Civili Brescia, Rheumatol & Clin Immunol Dept, Piazzale Spedali Civili 1, I-25123 Brescia, Italy
[2] Univ Brescia, Rheumatol & Clin Immunol Dept, Brescia, Italy
关键词
Systemic lupus erythematosus; damage; disease activity; antiphospholipid antibodies; neuropsychiatric damage; DISEASE-ACTIVITY; ANTIPHOSPHOLIPID ANTIBODIES; MORTALITY; INDEX; RISK; ASSOCIATION; PREDICTORS; SURVIVAL; PROFILE; COHORT;
D O I
10.1177/0961203317693096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The aim of this study was to determine the prevalence, predictors and progression of organ damage in a monocentric cohort of systemic lupus erythematosus patients with a long follow-up. Organ damage was assessed by the Systemic Lupus International Collaborating Clinics Damage Index one year after diagnosis and every five years. Disease activity was measured by the systemic lupus erythematosus disease activity index (SLEDAI)-2K at the beginning of the follow-up. Univariate and multivariable analyses were used to detect items associated with damage. A total of 511 systemic lupus erythematosus patients (92% females, 95% Caucasian), prospectively followed from 1972 to 2014, were included. Results After a mean disease duration of 16 years (SD: 9.5) and a mean follow-up of 12.9 years (SD: 8.8), 354 patients (69.3%) had accrued some damage: 49.7% developed mild/moderate damage, while 19.5% showed severe damage. Damage was evident in 40% of 511 patients one year after diagnosis, and its prevalence linearly increased over time. Longer disease duration, higher SLEDAI, severe Raynaud's, chronic alopecia and cerebral ischaemia were significantly associated with organ damage. No associations between damage and autoantibodies, including anti-dsDNA, anti-Sm or antiphospholipid antibodies, were observed. Anyway, antiphospholipid syndrome and anticardiolipin antibodies predicted the development of neuropsychiatric damage. The ocular, musculoskeletal and neuropsychiatric systems were the most frequently damaged organs, with a linear increase during follow-up. Conclusion A high rate of moderate and severe damage has been detected early in a wide cohort of young lupus patients, with a linear trend of increase over time. Disease activity and long duration of disease predict damage, while antiphospholipid antibodies play a role in determining neuropsychiatric damage.
引用
收藏
页码:1197 / 1204
页数:8
相关论文
共 40 条
  • [1] Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus - the Hopkins Lupus Cohort
    Al Sawah, Sarah
    Zhang, Xiang
    Zhu, Baojin
    Magder, Laurence S.
    Foster, Shonda A.
    Iikuni, Noriko
    Petri, Michelle
    [J]. LUPUS SCIENCE & MEDICINE, 2015, 2 (01):
  • [2] Systemic lupus erythematosus in three ethnic groups.: XX.: Damage as a predictor of further damage
    Alarcón, GS
    Roseman, JM
    McGwin, G
    Uribe, A
    Bastian, HM
    Fessler, BJ
    Baethge, BA
    Friedman, AW
    Reveille, JD
    [J]. RHEUMATOLOGY, 2004, 43 (02) : 202 - 205
  • [3] Risk factors for cataracts in systemic lupus erythematosus (SLE)
    Alderaan, Khaled
    Sekicki, Vuk
    Magder, Laurence S.
    Petri, Michelle
    [J]. RHEUMATOLOGY INTERNATIONAL, 2015, 35 (04) : 701 - 708
  • [4] ANTI-BETA(2)-GLYCOPROTEIN-I ANTIBODIES - A MARKER OF ANTIPHOSPHOLIPID SYNDROME
    BALESTRIERI, G
    TINCANI, A
    SPATOLA, L
    ALLEGRI, F
    PRATI, E
    CATTANEO, R
    VALESINI, G
    DELPAPA, N
    MERONI, P
    [J]. LUPUS, 1995, 4 (02) : 122 - 130
  • [5] Becker-Merok A, 2006, J RHEUMATOL, V33, P1570
  • [6] IDENTIFICATION OF ANTIBODIES TO ACIDIC ANTIGENS BY COUNTERIMMUNOELECTROPHORESIS
    BERNSTEIN, RM
    BUNN, CC
    HUGHES, GRV
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1982, 41 (05) : 554 - 555
  • [7] Bonakdar Zahra Sayed, 2011, J Res Med Sci, V16 Suppl 1, pS427
  • [8] Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
    Bruce, Ian N.
    O'Keeffe, Aidan G.
    Farewell, Vern
    Hanly, John G.
    Manzi, Susan
    Su, Li
    Gladman, Dafna D.
    Bae, Sang-Cheol
    Sanchez-Guerrero, Jorge
    Romero-Diaz, Juanita
    Gordon, Caroline
    Wallace, Daniel J.
    Clarke, Ann E.
    Bernatsky, Sasha
    Ginzler, Ellen M.
    Isenberg, David A.
    Rahman, Anisur
    Merrill, Joan T.
    Alarcon, Graciela S.
    Fessler, Barri J.
    Fortin, Paul R.
    Petri, Michelle
    Steinsson, Kristjan
    Dooley, Mary Anne
    Khamashta, Munther A.
    Ramsey-Goldman, Rosalind
    Zoma, Asad A.
    Sturfelt, Gunnar K.
    Nived, Ola
    Aranow, Cynthia
    Mackay, Meggan
    Ramos-Casals, Manuel
    van Vollenhoven, Ronald F.
    Kalunian, Kenneth C.
    Ruiz-Irastorza, Guillermo
    Lim, Sam
    Kamen, Diane L.
    Peschken, Christine A.
    Inanc, Murat
    Urowitz, Murray B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (09) : 1706 - 1713
  • [9] Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years
    Chambers, Sharon A.
    Allen, Elizabeth
    Rahman, Anisur
    Isenberg, David
    [J]. RHEUMATOLOGY, 2009, 48 (06) : 673 - 675
  • [10] The chronic damage in systemic lupus erythematosus is driven by flares, glucocorticoids and antiphospholipid antibodies: results from a monocentric cohort
    Conti, F.
    Ceccarelli, F.
    Perricone, C.
    Leccese, I.
    Massaro, L.
    Pacucci, V. A.
    Truglia, S.
    Miranda, F.
    Spinelli, F. R.
    Alessandri, C.
    Valesini, G.
    [J]. LUPUS, 2016, 25 (07) : 719 - 726